Jarislowsky, Fraser Ltd
- SEC CIK
- 0001123778
- Latest filing
- Oct 21, 2025
NVS holding history
Novartis AG in every 13F filed by Jarislowsky, Fraser Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q3 2025 holdings
- Shares (Q3 2025)
- 52,037
- Value
- $6.67M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 52,037 | $6.67M | <0.1% | −1,410−2.6% | Reduced | Holders |
| Q2 2025 | 53,447 | $6.47M | <0.1% | −700−1.3% | Reduced | Holders |
| Q1 2025 | 54,147 | $6.04M | <0.1% | +655+1.2% | Added | Holders |
| Q4 2024 | 53,492 | $5.21M | <0.1% | −3,275−5.8% | Reduced | Holders |
| Q3 2024 | 56,767 | $6.53M | <0.1% | +39+0.1% | Added | Holders |
| Q2 2024 | 56,728 | $6.04M | <0.1% | −4,585−7.5% | Reduced | Holders |
| Q1 2024 | 61,313 | $5.93M | <0.1% | −2,733−4.3% | Reduced | Holders |
| Q4 2023 | 64,046 | $6.47M | <0.1% | −2,993−4.5% | Reduced | Holders |
| Q3 2023 | 67,039 | $6.83M | <0.1% | −5,324−7.4% | Reduced | Holders |
| Q2 2023 | 72,363 | $7.30M | <0.1% | −8,466−10.5% | Reduced | Holders |
| Q1 2023 | 80,829 | $7.44M | <0.1% | −4,505−5.3% | Reduced | Holders |
| Q4 2022 | 85,334 | $7.74M | 0.1% | −8,906−9.5% | Reduced | Holders |
| Q3 2022 | 94,240 | $7.16M | <0.1% | −12,562−11.8% | Reduced | Holders |
| Q2 2022 | 106,802 | $9.03M | 0.1% | −23,803−18.2% | Reduced | Holders |
| Q1 2022 | 130,605 | $11.5M | 0.1% | −86,301−39.8% | Reduced | Holders |
| Q4 2021 | 216,906 | $19.0M | 0.1% | −57,630−21.0% | Reduced | Holders |
| Q3 2021 | 274,536 | $22.5M | 0.1% | −40,386−12.8% | Reduced | Holders |
| Q2 2021 | 314,922 | $28.7M | 0.1% | −124,014−28.3% | Reduced | Holders |
| Q1 2021 | 438,936 | $37.5M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.